Joon Lee
Stock Analyst at Truist Financial
(4.95)
# 131
Out of 4,376 analysts
550
Total ratings
56.3%
Success rate
34.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Joon Lee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PRAX Praxis Precision Medicines | Initiated Coverage: Buy | $700 → $715 | $254.00 | +181.50% | 30 | May 13, 2026 | |
| VYGR Voyager Therapeutics | Maintained: Buy | n/a | $3.33 | - | 16 | Mar 17, 2026 | |
| EDIT Editas Medicine | Maintained: Hold | n/a | $2.71 | - | 22 | Mar 17, 2026 | |
| SLDB Solid Biosciences | Maintained: Buy | n/a | $6.70 | - | 11 | Mar 13, 2026 | |
| VRTX Vertex Pharmaceuticals | Maintained: Buy | $525 | $446.83 | +17.49% | 16 | Mar 11, 2026 | |
| ANAB AnaptysBio | Maintained: Hold | $50 | $50.37 | -0.73% | 30 | Mar 9, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | n/a | $28.45 | - | 43 | Mar 5, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | n/a | $56.77 | - | 14 | Mar 3, 2026 | |
| CORT Corcept Therapeutics | Maintained: Buy | n/a | $72.62 | - | 38 | Mar 2, 2026 | |
| NTLA Intellia Therapeutics | Maintained: Buy | n/a | $13.54 | - | 29 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $51.84 | - | 24 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $70.97 | - | 11 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $5.73 | - | 41 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $42.80 | - | 3 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $31.27 | - | 31 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $238.57 | - | 26 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $232.32 | - | 37 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $76 | $21.91 | +246.87% | 29 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $36.10 | - | 2 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $3.17 | - | 8 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.50 | - | 24 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $891.32 | - | 38 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $10.30 | n/a | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $8.36 | n/a | 10 | Nov 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 → $65 | $7.42 | n/a | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $4 | $5.95 | n/a | 4 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $2.98 | n/a | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $6.20 | n/a | 1 | Aug 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $76 | $26.45 | n/a | 1 | Jun 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $20 | $5.47 | n/a | 1 | Jun 19, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $15.75 | n/a | 1 | Aug 8, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $21.56 | n/a | 1 | Aug 7, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $0.775 | n/a | 1 | Jul 28, 2014 |
Praxis Precision Medicines
May 13, 2026
Initiated Coverage: Buy
Price Target: $700 → $715
Current: $254.00
Upside: +181.50%
Voyager Therapeutics
Mar 17, 2026
Maintained: Buy
Price Target: n/a
Current: $3.33
Upside: -
Editas Medicine
Mar 17, 2026
Maintained: Hold
Price Target: n/a
Current: $2.71
Upside: -
Solid Biosciences
Mar 13, 2026
Maintained: Buy
Price Target: n/a
Current: $6.70
Upside: -
Vertex Pharmaceuticals
Mar 11, 2026
Maintained: Buy
Price Target: $525
Current: $446.83
Upside: +17.49%
AnaptysBio
Mar 9, 2026
Maintained: Hold
Price Target: $50
Current: $50.37
Upside: -0.73%
Viking Therapeutics
Mar 5, 2026
Maintained: Buy
Price Target: n/a
Current: $28.45
Upside: -
BioMarin Pharmaceutical
Mar 3, 2026
Maintained: Buy
Price Target: n/a
Current: $56.77
Upside: -
Corcept Therapeutics
Mar 2, 2026
Maintained: Buy
Price Target: n/a
Current: $72.62
Upside: -
Intellia Therapeutics
Mar 2, 2026
Maintained: Buy
Price Target: n/a
Current: $13.54
Upside: -
Mar 2, 2026
Maintained: Buy
Price Target: n/a
Current: $51.84
Upside: -
Feb 27, 2026
Maintained: Buy
Price Target: n/a
Current: $70.97
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.73
Upside: -
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $42.80
Upside: -
Feb 26, 2026
Maintained: Buy
Price Target: n/a
Current: $31.27
Upside: -
Feb 25, 2026
Maintained: Buy
Price Target: n/a
Current: $238.57
Upside: -
Feb 24, 2026
Maintained: Buy
Price Target: n/a
Current: $232.32
Upside: -
Feb 13, 2026
Maintained: Buy
Price Target: $90 → $76
Current: $21.91
Upside: +246.87%
Nov 10, 2025
Maintained: Buy
Price Target: n/a
Current: $36.10
Upside: -
Nov 6, 2025
Maintained: Buy
Price Target: n/a
Current: $3.17
Upside: -
Nov 5, 2025
Maintained: Buy
Price Target: n/a
Current: $5.50
Upside: -
Aug 1, 2025
Maintained: Buy
Price Target: n/a
Current: $891.32
Upside: -
Dec 4, 2024
Rated: Buy
Price Target: n/a
Current: $10.30
Upside: n/a
Nov 14, 2023
Maintained: Buy
Price Target: $18
Current: $8.36
Upside: n/a
Jan 17, 2023
Maintained: Buy
Price Target: $100 → $65
Current: $7.42
Upside: n/a
Dec 8, 2022
Maintained: Hold
Price Target: $7 → $4
Current: $5.95
Upside: n/a
May 5, 2022
Reiterated: Buy
Price Target: $14
Current: $2.98
Upside: n/a
Aug 8, 2019
Maintained: Buy
Price Target: $10
Current: $6.20
Upside: n/a
Jun 19, 2019
Initiated Coverage: Buy
Price Target: $76
Current: $26.45
Upside: n/a
Jun 19, 2019
Initiated Coverage: Buy
Price Target: $20
Current: $5.47
Upside: n/a
Aug 8, 2014
Maintained: Buy
Price Target: n/a
Current: $15.75
Upside: n/a
Aug 7, 2014
Reiterated: Buy
Price Target: $33
Current: $21.56
Upside: n/a
Jul 28, 2014
Maintained: Buy
Price Target: $14
Current: $0.775
Upside: n/a